Chison Medical Technologies Co

Chison Medical Technologies Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Chison Medical Technologies Co (688358.SS) as of Oct 31, 2026 is 79.53 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 93.83 % — a change of -15.23% (lower).

FCF Conversion

79.53 %

YoY

-15.23%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Chison Medical Technologies Co is 2025 79.53 % . FCF Conversion Rate (FCF/EBITDA) of Chison Medical Technologies Co was 2024 93.83 % . It decreases by -15.23% lower compared to the previous year.

The Chison Medical Technologies Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
69.06 CNY
Jan 1, 2019
68.52 CNY
Jan 1, 2020
51.75 CNY
Jan 1, 2021
0.69 CNY
Jan 1, 2022
10.90 CNY
Jan 1, 2023
35.43 CNY
Jan 1, 2024
93.83 CNY
Jan 1, 2025
79.53 CNY
The Chison Medical Technologies Co FCF Conversion history
YEARFCF ConversionYoY
79.53 %-15.23%
93.83 %+164.82%
35.43 %+225.18%
10.90 %+1,480.05%
0.69 %-98.67%
51.75 %-24.47%
68.52 %-0.78%
69.06 %-7.88%
74.96 %-34.17%
113.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chison Medical Technologies Co Stock analysis

What does Chison Medical Technologies Co do? Chison Medical Technologies Co Ltd generates revenue through the research and development, manufacturing, and sales of ultrasonic medical imaging equipment. The company develops core components such as color ultrasound probes, image processing algorithms, and image analysis software, which are integrated into complete color ultrasound machines. Its primary customers include domestic and foreign medical institutions, scientific research institutions, and strategic partners. The firm targets departments within hospitals such as ultrasound, anesthesiology, catheterization, obstetrics and gynecology, emergency, tumor surgery, breast surgery, nephrology, gastroenterology, and pain management. The company focuses on both domestic and overseas markets, leveraging its expertise in ultrasound technology to serve a wide range of healthcare settings. By providing comprehensive solutions that include equipment and technology development services, Chison Medical Technologies supports medical professionals in various specialties. Its product portfolio is designed to meet the specific needs of different hospital departments, enhancing diagnostic capabilities and patient care. Chison Medical Technologies Co Ltd’s business model centers on delivering high-quality ultrasound imaging solutions through continuous innovation in core components and software. The firm’s strategic partnerships with medical institutions and research organizations drive demand for its advanced imaging equipment. This approach ensures consistent revenue streams from both established and emerging healthcare markets. Chison Medical Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chison Medical Technologies Co stock

FCF Conversion Rate (FCF/EBITDA) of Chison Medical Technologies Co is 79.53 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Chison Medical Technologies Co changed from 93.83 % to 79.53 %, representing a -15.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Chison Medical Technologies Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Chison Medical Technologies Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Chison Medical Technologies Co

All Key Metrics — Chison Medical Technologies Co